| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99283 |
Emergency department visit for the evaluation and management, moderate severity |
17,621 |
16,690 |
$4.18M |
| 99284 |
Emergency department visit for the evaluation and management, high severity |
10,038 |
9,476 |
$2.15M |
| 99285 |
Emergency department visit for the evaluation and management, high severity with immediate threat to life |
5,592 |
5,283 |
$986K |
| G0378 |
Hospital observation service, per hour |
361 |
300 |
$428K |
| 96374 |
Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance |
3,004 |
2,809 |
$319K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
1,974 |
1,794 |
$264K |
| 99281 |
Emergency department visit for the evaluation and management, self-limited or minor |
714 |
689 |
$169K |
| 96361 |
Intravenous infusion, hydration; each additional hour |
1,465 |
1,357 |
$123K |
| 99282 |
Emergency department visit for the evaluation and management, low to moderate severity |
168 |
163 |
$36K |
| 96360 |
Intravenous infusion, hydration; initial, 31 minutes to 1 hour |
244 |
239 |
$20K |
| U0003 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r |
462 |
442 |
$8K |
| 96375 |
Therapeutic injection; each additional sequential IV push |
629 |
573 |
$7K |
| 80053 |
Comprehensive metabolic panel |
3,245 |
2,946 |
$6K |
| 70450 |
Computed tomography, head or brain; without contrast material |
407 |
389 |
$5K |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
5,445 |
4,885 |
$5K |
| 71045 |
Radiologic examination, chest; single view |
1,668 |
1,572 |
$5K |
| 93005 |
Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report |
2,458 |
2,242 |
$5K |
| 77067 |
Screening mammography, bilateral, including computer-aided detection |
56 |
51 |
$4K |
| 74177 |
Computed tomography, abdomen and pelvis; with contrast material |
108 |
106 |
$4K |
| 80307 |
Drug test(s), presumptive, any number of drug classes; immunoassay |
367 |
342 |
$3K |
| 71046 |
Radiologic examination, chest; 2 views |
469 |
439 |
$2K |
| 72084 |
|
52 |
52 |
$2K |
| 84484 |
|
1,427 |
1,206 |
$2K |
| 96365 |
Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour |
56 |
48 |
$2K |
| 87426 |
Infectious agent antigen detection, SARS-CoV-2 (COVID-19) |
425 |
390 |
$2K |
| 73630 |
|
262 |
224 |
$2K |
| 80048 |
Basic metabolic panel (calcium, ionized) |
1,159 |
1,034 |
$1K |
| 90471 |
Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine |
13 |
12 |
$1K |
| 81025 |
|
2,388 |
2,237 |
$1K |
| 74176 |
Computed tomography, abdomen and pelvis; without contrast material |
77 |
74 |
$1K |
| 83880 |
|
259 |
230 |
$1K |
| Q9967 |
Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml |
875 |
793 |
$1K |
| 87086 |
Culture, bacterial; quantitative colony count, urine |
1,118 |
1,064 |
$1K |
| C9803 |
Hospital outpatient clinic visit specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source |
496 |
473 |
$1K |
| 77063 |
Screening digital breast tomosynthesis, bilateral |
56 |
51 |
$990.27 |
| 83690 |
|
1,167 |
1,088 |
$832.46 |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
696 |
327 |
$742.66 |
| 73030 |
|
79 |
68 |
$667.18 |
| 81001 |
|
1,586 |
1,503 |
$610.90 |
| 36415 |
Collection of venous blood by venipuncture |
5,089 |
4,518 |
$540.18 |
| 85730 |
|
449 |
425 |
$461.80 |
| 84443 |
Thyroid stimulating hormone (TSH) |
150 |
138 |
$444.01 |
| U0005 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 |
226 |
214 |
$437.50 |
| 94640 |
Pressurized or nonpressurized inhalation treatment for acute airway obstruction |
265 |
198 |
$405.38 |
| 87491 |
Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe |
288 |
280 |
$346.41 |
| 87591 |
Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe |
288 |
280 |
$346.41 |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
65 |
60 |
$323.67 |
| 73610 |
|
56 |
53 |
$317.44 |
| 82550 |
|
354 |
329 |
$315.64 |
| 81003 |
|
758 |
707 |
$305.86 |
| 85379 |
|
145 |
139 |
$265.00 |
| 85610 |
|
474 |
450 |
$260.96 |
| 73562 |
|
48 |
38 |
$228.54 |
| 83735 |
|
240 |
192 |
$217.50 |
| 93010 |
Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only |
32 |
31 |
$184.84 |
| J7030 |
Infusion, normal saline solution , 1000 cc |
2,693 |
2,215 |
$176.42 |
| 87186 |
|
134 |
124 |
$175.20 |
| 83605 |
|
218 |
196 |
$160.00 |
| 87077 |
|
134 |
124 |
$148.39 |
| 82962 |
|
415 |
322 |
$117.60 |
| 84702 |
|
38 |
37 |
$114.94 |
| J1885 |
Injection, ketorolac tromethamine, per 15 mg |
1,898 |
1,563 |
$70.87 |
| J3490 |
Unclassified drugs |
713 |
504 |
$37.03 |
| 80076 |
|
78 |
70 |
$21.11 |
| J2270 |
Injection, morphine sulfate, up to 10 mg |
130 |
100 |
$17.16 |
| J1170 |
Injection, hydromorphone, up to 4 mg |
30 |
24 |
$16.42 |
| 85027 |
|
15 |
12 |
$15.04 |
| J2405 |
Injection, ondansetron hydrochloride, per 1 mg |
858 |
742 |
$14.93 |
| A4223 |
Infusion supplies not used with external infusion pump, per cassette or bag (list drugs separately) |
79 |
76 |
$14.00 |
| J7040 |
Infusion, normal saline solution, sterile (500 ml = 1 unit) |
13 |
12 |
$11.08 |
| J7512 |
Prednisone, immediate release or delayed release, oral, 1 mg |
615 |
418 |
$6.98 |
| J1100 |
Injection, dexamethasone sodium phosphate, 1 mg |
203 |
176 |
$6.45 |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
12 |
12 |
$6.30 |
| J0696 |
Injection, ceftriaxone sodium, per 250 mg |
378 |
332 |
$5.31 |
| 87081 |
|
30 |
28 |
$5.20 |
| J1200 |
Injection, diphenhydramine hcl, up to 50 mg |
153 |
130 |
$0.62 |
| Q0144 |
Azithromycin dihydrate, oral, capsules/powder, 1 gram |
17 |
16 |
$0.00 |
| Q0162 |
Ondansetron 1 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at the time of chemotherapy treatment, not to exceed a 48 hour dosage regimen |
76 |
70 |
$0.00 |
| J2003 |
Injection, lidocaine hydrochloride, 1 mg |
16 |
15 |
$0.00 |
| J2765 |
Injection, metoclopramide hcl, up to 10 mg |
63 |
57 |
$0.00 |
| A6257 |
Transparent film, sterile, 16 sq. in. or less, each dressing |
16 |
16 |
$0.00 |
| 87040 |
|
22 |
12 |
$0.00 |